Estimating the causal effects of smoking

Statistics in Medicine

Volumn 20, Issue 9-10, 2001, Pages 1395-1414

  Rubin, Donald B ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS;

ARTICLE; CHEMICAL INDUSTRY; EPIDEMIOLOGY; HEALTH CARE COST; HEALTH HAZARD; HYPOTHESIS; INCOME; MORBIDITY; MORTALITY; SMOKING; STATISTICS; TAX; TOBACCO INDUSTRY;

DELIVERY OF HEALTH CARE; HUMANS; MODELS, ECONOMIC; MODELS, STATISTICAL; SMOKING; TOBACCO INDUSTRY;

EID: 0035873787     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.677     Document Type: Article

References (34)

1. Rubin DB. What does it mean to estimate the causal effects of 'smoking'? Proceedings of the Section on Statistics in Epidemiology of the American Statistical Association 1998; 18-27.
2. Rubin DB. Statistical issues in the estimation of the causal effects of smoking due to the conduct of the tobacco industry. In Statistical Science in the Courtroom, Gastwirth JL (ed.). Springer-Verlag: New York, 2000.
3. Kleinman DG, Kupper LL, Morgenstern H. Epidemiological Research, Principles and Quantitative Methods. Van Norstrand Reinhold: New York, 1982; 160-163.
4. Warner KE, Chalouka FJ, Cook PJ, Manning WG, Newhouse JP, Novotny TE, Schelling TC, Townsend J. Criteria for determining an optimal cigarette tax: the economists's perspective. Tobacco Control 1995; 4:380-386.
5. Rybak DC, Phelps D. Smoked: The Inside Story of the Minnesota Tobacco Trial. MSP Books: Minneapolis, MN, 1998; 87.
6. Rothman KJ, Greenland S. Modern Epidemiology, 2nd edn. Lippincott-Raven: Philadelphia, 1998.
7. Lanes SF. Biologic interpretation of relative risk. Drug Safety, 1999; 19:75-77.
8. Miettinen OS. Proportion of disease caused or prevented by a given exposure, trait or intervention. American Journal of Epidemiology 1974; 99:325-332.
9. Harrison GW. Expert report, April 27, 1998: Health care expenditures attributable to smoking in Oklahoma. The State of Oklahoma, ex rel. et al., Plaintiffs, vs. R.J. Reynolds Tobacco Co. et al., Defendants, Case No. CJ-96-1499-L, District Court of Cleveland County, Oklahoma, 1998.
10. Zeger SL, Wyant T, Miller LS. Expert report, November 17, 1997: Smoking attributable health care expenditures: Blue Cross Blue Shield of Minnesota and State of Minnesota, 1978-1996. State of Minnesota and Blue Cross and Blue Shield of Minnesota, Plaintiffs, v. Philip Morris, Inc. et al., Defendants, District Court of Ramsey County, Minnesota, 1997.
11. Miller LS, Bartlett JC, Rice DP, Max WB, Novotny T. Expert report, August 8, 1994: Medical-care expenditures attributable to cigarette smoking: United States, 1993: methodology, descriptive statistics, parameter and expenditure estimates. Mike Moore, Attorney General ex rel, State of Mississippi, Plaintiff v. The American Tobacco Company et al., Defendants, Chancery Court of Jackson County, Mississippi, 1994.
12. Samet JM. Trial testimony at 3482 and Deposition testimony at 369-370. State of Minnesota and Blue Cross and Blue Shield of Minnesota, Plaintiffs, v. Philip Morris, Inc. et al., Defendants, Court File No. C1-94-8565 District Court of Ramsey County, Minnesota, 1998.
13. Lauer MS. Expert report, undated: Smoking and coronary heart disease and Supplemental report, October 22, 1998: Smoking and stroke. Iron Workers Local Union No. 17 Insurance Fund and Its Trustees et al., Plaintiffs, v. Philip Morris Incorporated et al., Defendants, Civil Action No. 1:97 CV 1422, District Court, Northeastern District of Ohio, 1998.
14. U.S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General. Publication No 1103, Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service. U.S. Government Printing Office: Washington, DC, 1964.
15. Engle HA. Verdict form for Phase I. Howard A. Engle, M.D. et al., Plaintiffs, v. R.J. Reynolds Tobacco Company et al., Defendants, General Jurisdiction Division Case No. 94-08273/c/a-22. Circuit Court of the Eleventh Judicial Circuit in and for Dade County, Florida, 1999.
16. Simpson EH. The interpretation of interaction in contingency tables. Journal of the Royal Statistical Society, Series B, 1951; 13:238-241.
17. Yule GU. Notes on the theory of association of attributes in statistics. Biometrika 1903; 2:121-134.
18. Bishop YMM. Effects of collapsing multidimensional contingency tables. Biometrics 1971; 27:545-562.
19. Geng Z. Collapsibility of relative risks in contingency tables with a response variable. Journal of the Royal Statistical Society, Series B, 1992; 54:585-598.
20. Greenland S, Robins JM. Identifiability, exchangeability, and epidemiological confounding. International Journal of Epidemiology 1986; 15:413-419.
21. Guo JH, Geng Z. Collapsibility of logistic regression coefficients. Journal of the Royal Statistical Society, Series B 1995; 57:263-267.
22. Rabinovitz FF. Expert Report, September 1, 1999: Estimation value of the tobacco industry's share of the indemnity and expenses of the Manville personal injury settlement trust. Robert A. Falise et al., Plaintiffs, v. The American Tobacco Company et al., Defendants, (CV97-76640), United States District Court, Eastern District of New York, 1999.
23. Walter SD. The estimation and interpretation of attributable risk in health research, Biometrics 1976; 32: 820-849.
24. O'Hara P, Connet JE, Lee WW, Nides M, Murray R, Wise R. Early and late weight gain following smoking cessation in the Lung Health Study. American Journal of Epidemiology 1998; 148:821-832.
25. Lillienfeld AM, Lillienfeld DE. Foundations of Epidemiology. Oxford University Press: Oxford, 1980.
26. U.S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General. Publication No. 89-8411, Reducing the Health Consequences of Smoking: 25 years of Progress. U.S. Government Printing Office: Washington, DC, 1989.
27. Hahn B, Lefkowitz D. Annual Expenses and Sources of Payment for Health Care Services (AHCPR Publication No. 93-0007), National Medical Expenditure Survey Research Findings 14. Agency for Health Care Policy and Research, Public Health Service: Rockville, MD, 1992.
28. Winkleby MA, Feldman HA, Murray DM. Joint analysis of three U.S. community intervention trials for reduction of cardiovascular disease risk. Journal of Clinical Epidemiology 1997; 50(6):645-658.
29. COMMIT Research Group. Community intervention trial for smoking cessation (COMMIT): I. Cohort results from a four-year community intervention and Community intervention trial for smoking cessation (COMMIT): II. Changes in adult cigarette smoking prevalence. American Journal of Public Health 1995; 85:183-200.
30. Rubin DB. Statistical issues in the estimation of the causal effects of smoking due to the conduct of the tobacco industry (Section 8). In Statistical Science in the Courtroom, Gastwirth JL (ed.). Springer-Verlag: New York, 2000.
31. U.S. Department of Health, Education, and Welfare, Public Health Service, Office of the Surgeon General. Publication No. 79-50066, Smoking and Health: A Report of the Surgeon General, U.S. Government Printing Office: Washington, DC, 1979.
32. Nicholson WJ. Expert report, August 30, 1999: Evaluation of cigarette smoking interactions in the development of asbestos-related disease. Falise et al., Plaintiffs, v. The American Tobacco Company et al., Defendants (CV97-76640), United States District Court, Eastern District of New York, 1999.
33. Chase GR, Kotin P, Crump K, Mitchell RS. Evaluation for compensation of asbestos-exposed individuals. II. Apportionment of risk for lung cancer and mesothelioma. Journal of Occupational Medicine 1985; 27: 189-255.
34. U.S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General. Preventing Tobacco Use Among Young People: A Report of the Surgeon General. Centers for Disease Control and Prevention, Government Printing Office, Washington, DC, 1994.